Last reviewed · How we verify

NCT03394547: PUMMP

Pulsed Electromagnetic Field Treatment for Painful Periods

Status unknown NA Last updated 13 June 2018
What this trial tests

NA trial testing Allay in Dysmenorrhea in 60 participants. Status unknown.

Timeline
3 November 2017
Primary endpoint
1 October 2018
1 October 2018

Quick facts

Lead sponsorBirmingham Women's NHS Foundation Trust
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment60
Start date3 November 2017
Primary completion1 October 2018
Estimated completion1 October 2018
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Birmingham Women's NHS Foundation Trust

Who can join

16 and older, female only, with Dysmenorrhea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A single-centre, randomised controlled, double blind study comparing use of the Allay pulsed shortwave therapy treatment versus a placebo device or no treatment for management of primary dysmenorrhea.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Dysmenorrhea

Currently open trials in the same condition.

Other Birmingham Women's NHS Foundation Trust trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03394547.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing